Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Current Deferred Revenue: 2022-2024

Historic Current Deferred Revenue for NewGenIvf (NIVF) over the last 3 years, with FY2024 value amounting to $63489.0.

  • NewGenIvf's Current Deferred Revenue rose 69991.18% to $63489.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $63489.0, marking a year-over-year increase of 69991.18%. This contributed to the annual value of $63489.0 for FY2024, which is 69991.18% up from last year.
  • NewGenIvf's Current Deferred Revenue amounted to $63489.0 in FY2024, which was up 69991.18% from $7937.0 recorded in FY2023.
  • NewGenIvf's 5-year Current Deferred Revenue high stood at $1.4 million for FY2022, and its period low was $7937.0 during FY2023.
  • Its 3-year average for Current Deferred Revenue is $477198.0, with a median of $63489.0 in 2024.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first crashed by 9941.65% in 2023, then skyrocketed by 69991.18% in 2024.
  • Annual analysis of 3 years shows NewGenIvf's Current Deferred Revenue stood at $1.4 million in 2022, then tumbled by 99.42% to $7937.0 in 2023, then surged by 699.91% to $63489.0 in 2024.
  • Its Current Deferred Revenue was $63489.0 in FY2024, compared to $7937.0 in FY2023 and $1.4 million in FY2022.